Physician profile
Imad Sabbagh
NPI 1578645941
$3,052.86
in general payments reported to CMS, 2019-2025
14 companies · $311 in 2025
The $311 reported for 2025 was more than what 84% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $264 · 2021: $222 · 2023: $2,055 · 2024: $19.28 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,215 · Food and Beverage: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,215.24 |
| Food and Beverage | $1,169.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,039.42 | 2020-2025 | Suresmile |
| Patterson Companies, INC. | $750.00 | 2023 | |
| Align Technology, INC. | $412.50 | 2020-2021 | |
| Envista Holdings Corporation | $234.53 | 2025 | Gutta Percha, Tf Adaptive, Optibond All-In-One |
| Straumann USA LLC | $186.82 | 2023 | |
| Coltene Whaledent INC. | $92.12 | 2019 | |
| A-Dec, INC. | $90.00 | 2019 | |
| Nobel Biocare USA | $77.62 | 2023 | Nobelactive |
| Kerr Corporation | $77.62 | 2023 | Tf Adaptive, Optibond All-In-One |
| Gc America INC. | $23.13 | 2025 | Mi Paste |
| Dmg America LLC | $23.07 | 2025 | |
| Ivoclar Vivadent, INC. | $19.28 | 2024 | |
| Philips North America LLC | $15.76 | 2025 | Oral Health Care Undivided |
| Kulzer, LLC | $10.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imad Sabbagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.